Organon & Co. (OGN)
13.74
-0.02
(-0.11%)
USD |
NYSE |
Oct 19, 15:29
Organon Cash from Operations (Annual) : 700.00M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 700.00M |
| December 31, 2024 | 939.00M |
| December 31, 2023 | 799.00M |
| December 31, 2022 | 858.00M |
| December 31, 2021 | 2.458B |
| Date | Value |
|---|---|
| December 31, 2020 | 2.187B |
| December 31, 2019 | 2.767B |
| December 31, 2018 | 3.687B |
| December 31, 2017 | 3.419B |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Merck & Co., Inc. | 16.47B |
| Viatris, Inc. | 2.316B |
| Pfizer Inc. | 11.70B |
| Pacira Biosciences, Inc. | 151.99M |
| Bristol Myers Squibb Co. | 14.16B |